Development and validation of a predictive score for venous thromboembolism in newly diagnosed non-small cell lung cancer

J Li, J Yi, L Hua, Y Su, M Huo, F Dou, Z Zhai, M Zhu… - Thrombosis …, 2021 - Elsevier
Introduction The risk of venous thromboembolism (VTE) varies among tumour types, and
different cancer type-specific risks for VTE prediction remain undefined. We aimed to …
被引用次数：11 相关文章

Development and validation of a predictive score for venous thromboembolism in newly diagnosed non-small cell lung cancer

J Li, J Yi, L Hua, Y Su, M Huo, F Dou… - Thrombosis …, 2021 - thrombosisresearch.com
Introduction The risk of venous thromboembolism (VTE) varies among tumour types, and
different cancer type-specific risks for VTE prediction remain undefined. We aimed to …

Development and validation of a predictive score for venous thromboembolism in newly diagnosed non-small cell lung cancer.

J Li, J Yi, L Hua, Y Su, M Huo, F Dou, Z Zhai… - Thrombosis …, 2021 - europepmc.org
Materials and methods We analysed data from a prospective cohort of patients with newly
diagnosed NSCLC. We then developed a VTE risk prediction model using data of patients …

Development and validation of a predictive score for venous thromboembolism in newly diagnosed non-small cell lung cancer

J Li, J Yi, L Hua, Y Su, M Huo, F Dou… - Thrombosis …, 2021 - pubmed.ncbi.nlm.nih.gov
Introduction The risk of venous thromboembolism (VTE) varies among tumour types, and
different cancer type-specific risks for VTE prediction remain undefined. We aimed to …